Results 21 to 30 of about 222,778 (216)

Post-COVID-19 syndrome

open access: yesAPIK Journal of Internal Medicine, 2023
Severe acute respiratory syndrome-CoV-2 infection has been known to cause an array of chronic consequences, most of which are yet to be studied in detail. These presentations are due to direct invasion of the tissues by the virus or other factors such as
Vasantha Kamath   +3 more
doaj   +1 more source

Women's Awareness about Post Covid-19 Syndrome [PDF]

open access: yesEgyptian Journal of Health Care
Background: The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, is leading to unknown and unusual health conditions that are challenging to manage.
Hanan Ibrahim Ahmed   +2 more
doaj   +1 more source

Oligosaccharides as Potential Regulators of Gut Microbiota and Intestinal Health in Post-COVID-19 Management

open access: yesPharmaceuticals, 2023
The COVID-19 pandemic has had a profound impact worldwide, resulting in long-term health effects for many individuals. Recently, as more and more people recover from COVID-19, there is an increasing need to identify effective management strategies for ...
Kit-Leong Cheong   +5 more
doaj   +1 more source

Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.

open access: yesPLoS ONE, 2021
BackgroundPost-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of symptoms or exaggeration of chronic diseases within a month after initial clinical and virological cure of the disease
Reaz Mahmud   +6 more
doaj   +1 more source

Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology

open access: yesNeurological Research and Practice, 2022
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to COVID-19 (COrona VIrus Disease-2019). SARS-CoV-2 acute infection may be associated with an increased incidence of neurological manifestations such as encephalopathy ...
Christiana Franke   +2 more
doaj   +1 more source

The co-administration of intranasal insulin and GLP-1RA as targeting drugs for prophylaxis and treatment of post COVID-19 smell and taste dysfunctions and brain fog

open access: yesAdvances in Biomedical and Health Sciences, 2023
The coronavirus disease (COVID-19) pandemic has resulted in high infection rates, significant morbidity, and postmortality among older adults, resulting in a global burden of COVID-19 survivors' long-term care.
Amr Ahmed, Aml M Barakat
doaj   +1 more source

Efficacy of Therapeutic Exercise in Reversing Decreased Strength, Impaired Respiratory Function, Decreased Physical Fitness, and Decreased Quality of Life Caused by the Post-COVID-19 Syndrome

open access: yesViruses, 2022
In the current global scenario, many COVID-19 survivors present a severe deterioration in physical strength, respiratory function, and quality of life due to persistent symptoms and post-acute consequences of SARS-CoV-2 infection.
Diego Fernández-Lázaro   +4 more
doaj   +1 more source

Identification of (20R)‐protopanaxadiol from Panax ginseng as a novel anti‐SARS‐CoV‐2 compound

open access: yesFEBS Open Bio, EarlyView.
We established a noninfectious BAC‐based SARS‐CoV‐2 replicon that enables antiviral screening under BSL‐2 conditions. Using this platform, we screened 373 food‐derived compounds and identified (20R)‐protopanaxadiol from Panax ginseng as a novel inhibitor of SARS‐CoV‐2 RNA replication, highlighting the value of safe replicon systems for antiviral ...
Midori Takeda   +4 more
wiley   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao   +5 more
wiley   +1 more source

Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy